Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Change in Account Payables (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Change in Account Payables for 2 consecutive years, with -$30000.0 as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 26.83% to -$30000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 186.88% year-over-year, with the annual reading at $1.6 million for FY2025, 186.88% up from the prior year.
  • Change in Account Payables hit -$30000.0 in Q4 2025 for Connect Biopharma Holdings, up from -$300000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.5 million in Q2 2025 to a low of -$1.8 million in Q1 2024.